中国春来(01969.HK)成功中标收购苏州科技大学天平学院总代价8亿元
格隆汇7月23日丨中国春来(01969.HK)公布,投标人(公司综合联属实体之一)于2019年7月22日收到中标通知书,确认其建议收购事项成功中标。
于2019年6月24日,苏州科技大学委托第三方招标平台发出招标公告,遴选转设学校举办者经营天平学院,拟最终将天平学院转设为民办普通高校,并由新的学校举办者拥有及独立经营。
公告显示,投标人须就招标支付初期资金人民币4亿元,其占代价的50%及将用于支付代价。
据悉,天平学院于2000年9月开始招生,并于2005年改设为独立学院。其为苏州科技大学及基金会共同举办、组织及出资以培养全日制本科生的独立学院。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.